BMRA (Biomerica) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMRA (Biomerica)

BMRA 2.562

+3.3%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey L. Henken who wrote (51)	10/26/1997 8:28:00 PM
From: Radam	Read Replies (1) of 170

Jeffrey--Were you suprised at BMRA's flat quarter? It had seemed to me that Lancer's manufacturing problems were being solved (most of LANZ earnings were in their 4th quarter, and from what I can tell this increase was due to improved gross margins---from an average of 37.5% for the first 3 quarters to 45% in the 4th quarter). I was looking forward to BMRA's 1st quarter, however I was disappointed that LANZ's gross margin fell back to 38.5% , resulting in flat earnings. In other words, if LANZ gross margins had held at 45% they would have contributed 4 to 5 cents to earnings rather than almost nothing. I'm afraid that as long as LANZ continues to dominate BMRA (68.5% of FY1997 revenues) we will see more of the same. I continue to hold my shares, however.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next